Related Experiment Video

Updated: Aug 29, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Chlamydia pneumoniae and future risk in patients with coronary heart disease

Moti Haim1, David Tanne, Alexander Battler

  • 1Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49 100, Israel. motih@netvision.net.il

International Journal of Cardiology
|January 20, 2004
PubMed

Insights

Previous Chlamydia pneumoniae infection does not increase future coronary heart disease risk in patients with existing heart conditions. This study found no association between prior Chlamydia pneumoniae exposure and recurrent coronary events.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • The role of infectious agents, such as Chlamydia pneumoniae, in the pathogenesis and progression of CHD remains an area of active research.
  • Understanding risk factors for recurrent coronary events is crucial for patient management.

Purpose of the Study:

  • To investigate the association between prior Chlamydia pneumoniae infection and the risk of future coronary events in patients already diagnosed with coronary heart disease.
  • To determine if serological evidence of past Chlamydia pneumoniae exposure predicts adverse cardiovascular outcomes.

Main Methods:

  • A prospective, nested case-control study design was employed.
  • The study utilized data from a bezafibrate trial for coronary heart disease treatment.
  • Baseline serum samples from 136 patients experiencing coronary events were compared to 136 matched controls without events, analyzing anti-Chlamydia pneumoniae IgG and IgA antibody titers.

Main Results:

  • No significant difference in mean IgG and IgA antibody titers was observed between patients who experienced future coronary events (cases) and those who did not (controls).
  • The relative odds of future coronary events were 1.0 for IgG and 0.74 for IgA seropositivity, with overlapping confidence intervals indicating no statistically significant association.
  • Adjusting for confounding variables did not alter these findings, and higher antibody titers did not correlate with increased coronary event risk.

Conclusions:

  • Prior exposure to Chlamydia pneumoniae is not associated with an elevated risk of recurrent coronary events in patients with established coronary heart disease.
  • These findings suggest that Chlamydia pneumoniae infection may not be a significant predictor of future cardiac events in this patient population.
  • Further research may be warranted to fully elucidate the complex interplay between infections and cardiovascular disease progression.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...